Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

First Light Asset Management

Latest statistics and disclosures from First Light Asset Management's latest quarterly 13F-HR filing:

Top 5 stock holdings are AXGN, NEO, SIBN, PVLA, CNTA, and represent 39.74% of First Light Asset Management's stock portfolio.
Added to shares of these 10 stocks: SIBN (+$61M), MDGL (+$32M), WVE (+$32M), TNDM (+$24M), IRON (+$23M), SLP (+$22M), APGE (+$22M), VERA (+$18M), PVLA (+$18M), SEPN (+$17M).
Started 6 new stock positions in SEPN, WVE, TNDM, IWO, APGE, DYN.
Reduced shares in these 10 stocks: , CNTA (-$34M), LENZ (-$32M), CDTX (-$28M), MRUS (-$21M), ORGO (-$19M), AXGN (-$19M), ANAB (-$17M), ADMA (-$16M), CAI (-$12M).
Sold out of its positions in ADMA, ALHC, CAI, CDTX, EVH, LENZ, PHLT, RDNT, RGEN, Senseonics Hldgs. GPCR, TECX, RARE, MRUS.
First Light Asset Management was a net seller of stock by $-11M.
First Light Asset Management has $1.3B in assets under management (AUM), dropping by 23.30%.
Central Index Key (CIK): 0001600004

Tip: Access up to 7 years of quarterly data

Positions held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for First Light Asset Management

First Light Asset Management holds 33 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Axogen Common Stocks (AXGN)	13.1	$171M	-9%	5.2M	32.73	View chart
Neogenomics Common Stocks (NEO)	9.0	$118M		10M	11.76	View chart
Si-bone Common Stocks (SIBN)	7.6	$99M	+162%	5.0M	19.72	View chart
Palvella Therapeutics Common Stocks (PVLA)	5.7	$74M	+30%	709k	104.67	View chart
Centessa Pharmaceuticals Common Stocks (CNTA)	4.4	$57M	-37%	2.3M	25.01	View chart
Crinetics Pharmaceuticals Common Stocks (CRNX)	4.3	$56M	+26%	1.2M	46.55	View chart
Atricure Common Stocks (ATRC)	3.6	$47M	+32%	1.2M	39.56	View chart
Vera Therapeutics Common Stocks (VERA)	3.4	$44M	+71%	870k	50.64	View chart
Disc Medicine Common Stocks (IRON)	3.2	$42M	+126%	523k	79.41	View chart
Amylyx Pharmaceuticals Common Stocks (AMLX)	3.1	$41M		3.4M	12.08	View chart
Edgewise Therapeutics Common Stocks (EWTX)	3.0	$39M	+11%	1.6M	24.82	View chart
Madrigal Pharmaceuticals Common Stocks (MDGL)	3.0	$39M	+479%	67k	582.34	View chart
Twist Bioscience Corporation Common Stocks (TWST)	2.8	$36M	-4%	1.1M	31.72	View chart
Simulations Plus Common Stocks (SLP)	2.7	$36M	+156%	2.0M	18.23	View chart
Rhythm Pharmaceuticals Common Stocks (RYTM)	2.4	$32M	+63%	296k	107.04	View chart
Wave Life Sciences Common Stocks (WVE)	2.4	$32M	NEW	1.9M	17.00	View chart
Anaptys Bio Common Stocks (ANAB)	2.4	$31M	-34%	646k	48.48	View chart
Health Catalyst Common Stocks (HCAT)	2.4	$31M	-3%	13M	2.39	View chart
Guardant Health Common Stocks (GH)	2.3	$30M	+5%	295k	102.14	View chart
Irhythm Technologies Common Stocks (IRTC)	2.1	$27M		154k	177.44	View chart
Establishment Labs Holdings Common Stocks (ESTA)	2.1	$27M	-10%	373k	72.88	View chart
908 Devices Common Stocks (MASS)	1.9	$25M	+92%	4.8M	5.25	View chart
Koru Medical Systems Common Stocks (KRMD)	1.9	$25M	-7%	4.2M	5.81	View chart
Tandem Diabetes Care Common Stocks (TNDM)	1.8	$24M	NEW	1.1M	21.98	View chart
Apogee Therapeutics Common Stocks (APGE)	1.6	$22M	NEW	285k	75.48	View chart
Neuropace Common Stocks (NPCE)	1.6	$21M		1.3M	15.44	View chart
Mimedx Group Common Stocks (MDXG)	1.6	$21M	-16%	3.0M	6.77	View chart
Organogenesis Holdings Common Stocks (ORGO)	1.5	$20M	-48%	3.9M	5.18	View chart
Septerna Common Stocks (SEPN)	1.3	$17M	NEW	621k	27.88	View chart
Abivax Sa- Common Stocks (ABVX)	0.9	$12M	-7%	89k	134.85	View chart
Butterfly Network Common Stocks (BFLY)	0.8	$11M	+149%	2.8M	3.80	View chart
Dyne Therapeutics Common Stocks (DYN)	0.2	$3.0M	NEW	155k	19.56	View chart
Ishares Russell 2000 Growth Etf Common Stocks (IWO)	0.0	$246k	NEW	760.00	323.01	View chart

Past Filings by First Light Asset Management

SEC 13F filings are viewable for First Light Asset Management going back to 2013

First Light Asset Management 2025 Q4 filed Feb. 17, 2026
First Light Asset Management 2025 Q3 filed Nov. 14, 2025
First Light Asset Management 2025 Q2 filed Aug. 14, 2025
First Light Asset Management 2025 Q1 filed May 15, 2025
First Light Asset Management 2024 Q4 filed Feb. 14, 2025
First Light Asset Management 2024 Q3 filed Nov. 14, 2024
First Light Asset Management 2024 Q2 filed Aug. 14, 2024
First Light Asset Management 2024 Q1 filed May 15, 2024
First Light Asset Management 2023 Q4 filed Feb. 14, 2024
First Light Asset Management 2023 Q3 filed Nov. 14, 2023
First Light Asset Management 2023 Q2 filed Aug. 14, 2023
First Light Asset Management 2023 Q1 filed May 15, 2023
First Light Asset Management 2022 Q4 filed Feb. 14, 2023
First Light Asset Management 2022 Q3 filed Nov. 14, 2022
First Light Asset Management 2022 Q2 filed Aug. 12, 2022
First Light Asset Management 2022 Q1 filed May 13, 2022

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z